BrainJuicer Group PLC
19 January 2007
19 January 2007
BrainJuicer Group PLC
('BrainJuicer' or 'the Company')
Grant of Options
BrainJuicer, one of Europe's leading online market research agencies, announces
that on 19 January 2007 the executive directors were granted options over
Ordinary Shares of 1p each under the BrainJuicer Group PLC Share Option Scheme
as follows:
Executive Director Options granted on Total options held on
19 January 2007 19 January 2007
John Kearon 60,213 60,213
James Geddes 60,213 289,023
These new options were granted at a subscription price of 162.5p per ordinary
share, that being the closing mid-market price of the Company's Ordinary Shares
on 18 January 2007. In each case the new options vest in one-thirds on 1
January 2008, 1 January 2009 and 1 January 2010.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.